Cures Start Here. Fred Hutchinson Cancer Research Center (Fred Hutch), home of three Nobel laureates, is an independent, nonprofit research institution dedicated to the development and advancement of biomedical research to eliminate cancer and other potentially fatal diseases. Recognized internationally for its pioneering work in bone-marrow transplantation, Fred Hutchs five scientific divisions collaborate to form a unique environment for conducting basic and applied science. The Fred Hutch, in collaboration with its clinical and research partners, the University of Washington and Seattle Childrens, is the only National Cancer Institute-designated comprehensive cancer center in the Pacific Northwest. Careers Start Here.
The Gujral Lab at the Fred Hutchinson Cancer Research Center has an opening for a postdoctoral fellow interested in studying the tumor microenvironment. Our lab combines approaches from molecular genetics with cell and systems biology to study the interactions between tumor cells and host cells in the tumor microenvironment.
Although progress has been made in the past several decades in understanding and developing treatments for cancer, there is still a huge unmet need for effective treatment to stop metastasis which accounts for 90% of deaths due to cancer. A major focus of our lab is to study how cancer cells and immune cells influence the growth and functions of each other in advanced stage solid tumors by integrating recently developed proteomics and computational methods with specific cellular system ( Gujral et al., PNAS, 2014 , Gujral et al., Cell, 2014 .) In our lab, we leverage different data-driven approaches (e.g. Protein arrays, transcriptomic profiling, high throughput live cell imaging, screening tools) to inform the work of focused biology which utilizes conventional tools including transgenic murine models, molecular and biochemical approaches. The goal is to be able to study cell system as a whole and at microscopic levels in order to find solutions for cancer and other diseases.
Successfulcandidates will have:
A recent PhD in a relevant field
Knowledge and experience in cancer biology, biochemistry, and immunology
Track record of productive research, with at least one first-author publication
Experience with in vivo cancer models is preferred
Please include a cover letter with your application, describing your past research accomplishments as well as your interest and suitability for this position.
Our Commitment to Diversity
We are proud to be an Equal Employment Opportunity (EEO) and Vietnam Era Veterans Readjustment Assistance Act (VEVRAA) Employer. We are committed to cultivating a workplace in which diverse perspectives and experiences are welcomed and respected. We do not discriminate on the basis of race, color, religion, creed, ancestry, national origin, sex, age, disability (physical or mental), marital or veteran status, genetic information, sexual orientation, gender identity, political ideology, or membership in any other legally protected class. We are an Affirmative Action employer. We encourage individuals with diverse backgrounds to apply and desire priority referrals of protected veterans. If due to a disability you need assistance/and or a reasonable accommodation during the application or recruiting process, please send a request to our Employee Services Center at firstname.lastname@example.org or by calling 206-667-4700.
At Fred Hutchinson Cancer Research Center, teams of world-renowned scientists and humanitarians work together to prevent, diagnose and treat cancer, HIV/AIDS and other diseases. Researchers are discovering new ways to detect cancers earlier, improve treatments, and learn how to prevent cancers from growing. Although Fred Hutchinson opened its doors in 1975, its history began about 20 years before that. In 1962 Fred Hutchinson envisioned a center devoted to studying cancer, a disease that took his brother’s life. Today Fred Hutchinson is contributing to the next waves of breakthrough treatments and prevention strategies. Fred Hutchinson collaborates with the Seattle Cancer Alliance, the National Cancer Institute, and the University of Washington.